BN Business News
Adicionar empresa →
Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.

Negócios · 09/08/20131 min de leitura

Food and Drug Administration Patient Network Annual Meeting; Demystifying Food and Drug Administration: An Exploration of Drug Development Hosted by the Food and Drug Administration Office of Health and Constituent Affairs, Formerly the Office of Special Health Issues

Tradução automática local · Idioma original da fonte

Resumo

The Food and Drug Administration (FDA) is announcing a meeting for patients, caregivers, patient advocates, as well as patient advocate and health professional groups, to provide a primer on drug product development and explore patient involvement in drug development. The meeting will serve as a forum for FDA's patient stakeholders and the general public, including health professionals, academia, and industry to learn about FDA's role in, and various regulatory issues related to drug development, analyze where in the process patient input may be most practical and most valuable, and explore practicable approaches to incorporating meaningful patient input that will represent broad patient perspectives in drug development and regulatory decision making. Specifically, this meeting will provide information and facilitate a discussion about: FDA's role in drug development and where and how patients can take an active role.

Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →

Explorar análises

Análises empresariais →